#QualityReporting #HospitalLeadership #HealthcareAI #CoreMobile #ClinicalExcellence Koray Atalag, MD, PhD GALATA-Digital 3K followers Such an elegant and meaningful way of using FHIR with dQMs and CQL - key for advancing quality measurement, precise clinical decision support, and addressing care gaps with the secondary use of data collected for clinical use
The abdominal wall has a generous layer of subcutaneous fat, plenty of surface area, and fewer nerve endings than other areas, which generally means a less painful experience
Sometimes, an abscess forms outside an inflamed appendix
GLP-1 weight loss medications have become a cornerstone of medically supervised weight loss , helping patients reduce appetite, improve portion control, and support sustainable fat loss
Your Options Request a formulary exception your doctor can argue medical necessity What to do if Wegovy is not covered Cardiovascular risk reduction if you have heart disease risk factors, Wegovy's FDA-approved indication (March 2024) strengthens your case Consider Zepbound as of October 1, 2026 it returns as an "additional preferred option" alongside Wegovy on most Aetna/CVS Caremark plans [10] Zepbound coverage on Aetna Switch plans during open enrollment if your employer offers multiple options, check for GLP-1 coverage Explore self-pay options NovoCare ($349/mo) and patient assistance may help Wegovy Cost Guide About Wegovy's FDA Approvals Important: Sleep Apnea Coverage Goes to Zepbound, Not Wegovy Note: Zepbound (tirzepatide), not Wegovy, was FDA-approved to treat obstructive sleep apnea (OSA) in adults with obesity on December 20, 2024
